Willard H Dere
CIK 1311569 · last filed 2026-07-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BMRN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
105 DIGITIAL DRIVE
NOVATO, CA 94949
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MCRB | Director | 1,587 | $1.98 | $3.1K | $0 | 11 | 2026-07-10 |
| MGX | Director | — | $0.77 | — | $0 | 3 | 2026-06-11 |
| BMRN | Director | 46,440 | $55.75 | $2.59M | -$547.6K | 13 | 2026-06-04 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | Director | 0 | $29.08 | $0 | $0 | 17 | 2026-01-06 |
| Radius Health, Inc. (RDUS) Delisted | Director | 1,895 | $30.00 | $56.9K | -$71.9K | 15 | 2022-08-15 |
Recent Filings · Page 4 of 7
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-25 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-20 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-30 | BMRN | Sell (S) | −4,430 | -$547.6K | EDGAR |
| 2020-06-29 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-22 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2020-05-29 | BMRN | Grant (A) | +4,300 | $0 | EDGAR |
| 2020-02-28 | Radius Health, Inc. (RDUS) Delisted | Sell (S) | −1,925 | -$34.6K | EDGAR |
| 2020-02-24 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | +5,500 | $0 | EDGAR |
| 2020-01-03 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-14 | MCRB | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.